QIAGEN Debt to Equity Ratio 2006-2018 | QGEN

Current and historical debt to equity ratio values for QIAGEN (QGEN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. QIAGEN debt/equity for the three months ending June 30, 2018 was 0.53.
QIAGEN Annual Debt/Equity Ratio
2017 0.69
2016 0.41
2015 0.41
2014 0.44
2013 0.31
2012 0.31
2011 0.23
2010 0.35
2009 0.40
2008 0.67
2007 0.71
2006 0.90
2005 0.47
QIAGEN Quarterly Debt/Equity Ratio
Q2 2018 0.70
Q1 2018 0.69
Q4 2017 0.69
Q3 2017 0.68
Q2 2017 0.55
Q1 2017 0.44
Q4 2016 0.41
Q3 2016 0.40
Q2 2016 0.41
Q1 2016 0.40
Q4 2015 0.41
Q3 2015 0.42
Q2 2015 0.41
Q1 2015 0.42
Q4 2014 0.44
Q3 2014 0.43
Q2 2014 0.43
Q1 2014 0.43
Q4 2013 0.31
Q3 2013 0.32
Q2 2013 0.33
Q1 2013 0.32
Q4 2012 0.31
Q3 2012 0.25
Q2 2012 0.25
Q1 2012 0.23
Q4 2011 0.23
Q3 2011 0.31
Q2 2011 0.34
Q1 2011 0.34
Q4 2010 0.35
Q3 2010 0.37
Q2 2010 0.41
Q1 2010 0.41
Q4 2009 0.42
Q3 2009 0.43
Q2 2009 0.64
Q1 2009 0.67
Q4 2008 0.67
Q3 2008 0.68
Q2 2008 0.67
Q1 2008 0.68
Q4 2007 0.71
Q3 2007 0.74
Q2 2007 0.82
Q1 2007 0.87
Q4 2006 0.90
Q3 2006 0.96
Q2 2006 0.00
Q1 2006 0.00
Q4 2005 0.47
Q3 2005 0.48
Q2 2005 0.51
Q1 2005 0.53
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $8.552B $1.418B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $132.755B 15.24
Gilead Sciences (GILD) United States $97.887B 10.86
Biogen (BIIB) United States $69.580B 14.75
Celgene (CELG) United States $61.699B 12.32
Illumina (ILMN) United States $52.650B 65.96
Vertex Pharmaceuticals (VRTX) United States $46.021B 104.70
Regeneron Pharmaceuticals (REGN) United States $42.172B 23.71
Alexion Pharmaceuticals (ALXN) United States $27.187B 20.43
BioMarin Pharmaceutical (BMRN) United States $17.375B 0.00
Incyte (INCY) United States $14.156B 475.64
Seattle Genetics (SGEN) United States $12.348B 0.00
Sarepta Therapeutics (SRPT) United States $9.806B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.520B 0.00
Exact Sciences (EXAS) United States $9.364B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.881B 57.02
BeiGene (BGNE) Cayman Islands $8.816B 0.00
Bluebird Bio (BLUE) United States $7.601B 0.00
Bio-Techne Corp (TECH) United States $7.398B 49.47
Alkermes (ALKS) Ireland $6.455B 0.00
Galapagos (GLPG) Belgium $5.805B 0.00
Ligand Pharmaceuticals (LGND) United States $5.484B 48.57
Exelixis (EXEL) United States $4.995B 16.27
Ultragenyx Pharmaceutical (RARE) United States $4.259B 0.00
Immunomedics (IMMU) United States $4.021B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.378B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.375B 0.00
Emergent Biosolutions (EBS) United States $3.299B 26.28
Myriad Genetics (MYGN) United States $3.281B 36.72
Array BioPharma (ARRY) United States $3.258B 0.00
Horizon Pharma Public (HZNP) Ireland $3.136B 17.75
Blueprint Medicines (BPMC) United States $3.055B 0.00
Ascendis Pharma (ASND) Denmark $2.782B 0.00
China Biologic Products (CBPO) China $2.701B 17.84
Acceleron Pharma (XLRN) United States $2.606B 0.00
Reata Pharmaceuticals (RETA) United States $2.598B 0.00
MyoKardia (MYOK) United States $2.531B 0.00
Halozyme Therapeutics (HALO) United States $2.530B 33.71
ACADIA Pharmaceuticals (ACAD) United States $2.521B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.508B 0.00
Medicines (MDCO) United States $2.490B 0.00
Genomic Health (GHDX) United States $2.479B 138.30
Repligen (RGEN) United States $2.420B 81.24
Akcea Therapeutics (AKCA) United States $2.398B 0.00
Amicus Therapeutics (FOLD) United States $2.309B 0.00
REGENXBIO (RGNX) United States $2.241B 35.20
AnaptysBio (ANAB) United States $2.231B 0.00
Arena Pharmaceuticals (ARNA) United States $2.159B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.107B 0.00
CRISPR THERAPTC (CRSP) Switzerland $2.100B 0.00
Spark Therapeutics (ONCE) United States $2.087B 0.00
Global Blood Therapeutics (GBT) United States $2.069B 0.00
Cambrex (CBM) United States $2.035B 16.32
Allakos (ALLK) United States $2.006B 0.00
Denali Therapeutics (DNLI) United States $1.983B 0.00
Mirati Therapeutics (MRTX) United States $1.919B 0.00
G1 THERAPEUTICS (GTHX) United States $1.891B 0.00
Myovant Sciences (MYOV) United Kingdom $1.827B 0.00
Solid Biosciences (SLDB) United States $1.815B 0.00
Atara Biotherapeutics (ATRA) United States $1.807B 0.00
Puma Biotechnology (PBYI) United States $1.806B 0.00
Rubius Therapeutics (RUBY) United States $1.804B 0.00
Clovis Oncology (CLVS) United States $1.705B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.682B 0.00
Insmed (INSM) United States $1.642B 0.00
Sangamo Therapeutics (SGMO) United States $1.601B 0.00
Aimmune Therapeutics (AIMT) United States $1.591B 0.00
WAVE Life Sciences (WVE) Singapore $1.534B 0.00
Innoviva (INVA) United States $1.522B 9.77
Biohaven Pharmaceutical Holding (BHVN) United States $1.512B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.472B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.467B 0.00
Editas Medicine (EDIT) United States $1.435B 0.00
UniQure (QURE) Netherlands $1.428B 0.00
IMMURON LTD (IMRN) Australia $1.406B 0.00
Audentes Therapeutics (BOLD) United States $1.405B 0.00
DBV Technologies (DBVT) France $1.402B 0.00
Lion Biotechnologies (IOVA) United States $1.295B 0.00
Cellectis (CLLS) France $1.206B 0.00
AVROBIO (AVRO) United States $1.179B 0.00
NeoGenomics (NEO) United States $1.159B 202.86
Intellia Therapeutics (NTLA) United States $1.157B 0.00
Intra-Cellular Therapies (ITCI) United States $1.153B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.150B 0.00
Retrophin (RTRX) United States $1.137B 0.00
Athenex (ATNX) United States $1.123B 0.00
Apellis Pharmaceuticals (APLS) United States $1.117B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.114B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.110B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.106B 0.00
Viking Therapeutics (VKTX) United States $1.104B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.099B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.096B 0.00
Coherus BioSciences (CHRS) United States $1.082B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.053B 2010.00
Geron (GERN) United States $1.003B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.988B 0.00
Revance Therapeutics (RVNC) United States $0.927B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.926B 0.00
Cara Therapeutics (CARA) United States $0.911B 0.00
Aptinyx (APTX) United States $0.894B 0.00
Amarin (AMRN) Ireland $0.874B 0.00
Acorda Therapeutics (ACOR) United States $0.864B 18.02
Heska (HSKA) United States $0.832B 71.63
CytomX Therapeutics (CTMX) United States $0.813B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.779B 0.00
Fate Therapeutics (FATE) United States $0.778B 0.00
InflaRx (IFRX) Germany $0.774B 0.00
Dynavax Technologies (DVAX) United States $0.751B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.717B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.713B 0.00
Epizyme (EPZM) United States $0.712B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.712B 0.00
MiMedx (MDXG) United States $0.703B 30.14
UROGEN PHARMA (URGN) Israel $0.681B 0.00
UNITY Biotechnology (UBX) $0.677B 0.00
ObsEva SA (OBSV) Switzerland $0.662B 0.00
Kura Oncology (KURA) United States $0.649B 0.00
Verastem (VSTM) United States $0.637B 0.00
Mesoblast (MESO) Australia $0.631B 0.00
ANI Pharmaceuticals (ANIP) United States $0.626B 12.40
Novavax (NVAX) United States $0.612B 0.00
Scholar Rock Holding (SRRK) United States $0.611B 0.00
Abeona Therapeutics (ABEO) United States $0.605B 0.00
Vericel (VCEL) United States $0.602B 0.00
Arcus Biosciences (RCUS) United States $0.601B 0.00
Anika Therapeutics (ANIK) United States $0.598B 25.17
Replimune (REPL) United States $0.590B 0.00
AC Immune SA (ACIU) Switzerland $0.566B 0.00
BeyondSpring (BYSI) United States $0.561B 0.00
Senesco Technologies (ELOX) United States $0.559B 0.00
Stemline Therapeutics (STML) United States $0.536B 0.00
Prothena (PRTA) Ireland $0.531B 0.00
RA PHARMCTL INC (RARX) United States $0.529B 0.00
Zymeworks (ZYME) Canada $0.529B 0.00
Arbutus Biopharma (ABUS) Canada $0.526B 0.00
Zealand Pharma (ZEAL) Denmark $0.513B 0.00
Sorrento Therapeutics (SRNE) United States $0.502B 86.00
MediciNova (MNOV) United States $0.500B 0.00
Five Prime Therapeutics (FPRX) United States $0.494B 0.00
Aduro Biotech (ADRO) United States $0.490B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.486B 0.00
Cytokineticsorporated (CYTK) United States $0.464B 0.00
Sinovac Biotech (SVA) China $0.448B 0.00
Kindred Biosciences (KIN) United States $0.444B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.440B 0.00
Syros Pharmaceuticals (SYRS) United States $0.435B 0.00
Inovio Pharmaceuticals (INO) United States $0.433B 0.00
Merus (MRUS) Netherlands $0.430B 0.00
Eidos Therapeutics (EIDX) United States $0.424B 0.00
ResTORbio (TORC) United States $0.422B 0.00
Evelo Biosciences (EVLO) United States $0.402B 0.00
Osiris Therapeutics (OSIR) United States $0.385B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.385B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.379B 0.00
Kadmon Holdings (KDMN) United States $0.378B 0.00
Albireo Pharma (ALBO) United States $0.376B 0.00
Kezar Life Sciences (KZR) United States $0.375B 0.00
Magenta Therapeutics (MGTA) United States $0.373B 0.00
Adverum Biotechnologies (ADVM) United States $0.370B 0.00
Cellular Biomedicine (CBMG) United States $0.369B 0.00
Unum Therapeutics (UMRX) United States $0.363B 0.00
MeiraGTx Holdings (MGTX) United States $0.355B 0.00
PDL BioPharma (PDLI) United States $0.353B 4.96
Clementia Pharmaceuticals (CMTA) Canada $0.351B 0.00
Selecta Biosciences (SELB) United States $0.351B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.340B 0.00
BioTime (BTX) United States $0.334B 0.00
Synlogic (SYBX) United States $0.331B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.321B 0.00
Liquidia Technologies (LQDA) United States $0.308B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.308B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.306B 0.00
Seres Therapeutics (MCRB) United States $0.305B 0.00
Celcuity (CELC) United States $0.301B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.289B 0.00
ADMA Biologics Inc (ADMA) United States $0.285B 0.00
Axovant Sciences (AXON) United Kingdom $0.278B 0.00
TOCAGEN INC (TOCA) United States $0.272B 0.00
Celyad SA (CYAD) Belgium $0.272B 0.00
Mersana Therapeutics (MRSN) United States $0.271B 0.00
Athersys (ATHX) United States $0.269B 0.00
MannKind (MNKD) United States $0.266B 0.00
Kala Pharmaceuticals (KALA) United States $0.264B 0.00
NantKwest (NK) United States $0.261B 0.00
Menlo Therapeutics (MNLO) United States $0.261B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.259B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.252B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.250B 0.00
Kamada (KMDA) Israel $0.242B 18.75
Idera Pharmaceuticals (IDRA) United States $0.230B 0.00
Agenus (AGEN) United States $0.227B 0.00
Allena Pharmaceuticals (ALNA) United States $0.215B 0.00
Constellation Pharmaceuticals (CNST) United States $0.211B 0.00
ChromaDex (CDXC) United States $0.209B 0.00
Protagonist Therapeutics (PTGX) United States $0.207B 0.00
Strongbridge Biopharma (SBBP) United States $0.203B 0.00
Compugen (CGEN) Israel $0.203B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.202B 0.00
Palatin Technologies (PTN) United States $0.202B 8.33
Clearside Biomedical (CLSD) United States $0.200B 0.00
Enzo Biochem (ENZ) United States $0.193B 0.00
Spero Therapeutics (SPRO) United States $0.186B 0.00
Cue Biopharma (CUE) United States $0.185B 0.00
Cohbar (CWBR) United States $0.185B 0.00
Monster Digital (INNT) United States $0.179B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) $0.178B 0.00
Krystal Biotech (KRYS) United States $0.175B 0.00
Signal Genetics (MGEN) United States $0.172B 0.00
BioDelivery Sciences (BDSI) United States $0.170B 0.00
Mustang Bio (MBIO) United States $0.167B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.165B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.164B 0.00
Eleven Biotherapeutics (SESN) United States $0.161B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.158B 0.00
Pfenex (PFNX) United States $0.156B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.154B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.153B 0.00
Checkpoint Therapeutics (CKPT) United States $0.152B 0.00
Cerecor (CERC) United States $0.150B 17.92
Pluristem Therapeutics (PSTI) Israel $0.148B 0.00
Provention Bio (PRVB) United States $0.146B 0.00
Intec Pharma (NTEC) Israel $0.141B 0.00
PSivida (EYPT) United States $0.140B 0.00
OVID THERAPEUTC (OVID) United States $0.138B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.138B 0.00
XOMA (XOMA) United States $0.133B 14.03
Tapimmune (TPIV) United States $0.132B 0.00
Trevena (TRVN) United States $0.131B 0.00
Organovo Holdings (ONVO) United States $0.129B 0.00
Motif Bio Plc (MTFB) United States $0.125B 0.00
VBI Vaccines (VBIV) United States $0.124B 0.00
Catalyst Biosciences (CBIO) United States $0.121B 0.00
BioXcel Therapeutics (BTAI) United States $0.118B 0.00
Cidara Therapeutics (CDTX) United States $0.118B 0.00
Anavex Life Sciences (AVXL) United States $0.113B 0.00
Aptevo Therapeutics (APVO) United States $0.112B 0.00
Protalix BioTherapeutics (PLX) Israel $0.107B 0.00
Alcobra (ARCT) United States $0.105B 0.00
Cel-Sci (CVM) United States $0.105B 0.00
XBiotech (XBIT) United States $0.100B 0.00
Leap Therapeutics (LPTX) United States $0.097B 0.00
Neothetics (EVFM) United States $0.097B 0.00
ARIDIS PHARMACT (ARDS) United States $0.095B 0.00
ScPharmaceuticals (SCPH) United States $0.095B 0.00
Proteostasis Therapeutics (PTI) United States $0.095B 0.00
Vaccinex (VCNX) United States $0.094B 0.00
Aptose Biosciences (APTO) Canada $0.089B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.089B 0.00
NewLink Genetics (NLNK) United States $0.088B 0.00
Fortress Biotech (FBIO) United States $0.086B 0.00
Axsome Therapeutics (AXSM) United States $0.085B 0.00
Ophthotech (OPHT) United States $0.084B 0.55
Cocrystal Pharma (COCP) United States $0.083B 0.00
Prima BioMed (IMMP) Australia $0.082B 0.00
VolitionRX (VNRX) Singapore $0.082B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.081B 0.00
Evogene (EVGN) Israel $0.081B 0.00
Chiasma (CHMA) United States $0.080B 0.00
Sophiris Bio (SPHS) United States $0.080B 0.00
Orgenesis (ORGS) United States $0.080B 0.00
Applied Genetic Technologies (AGTC) United States $0.080B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.076B 0.00
Asterias Biotherapeutics (AST) United States $0.075B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.074B 0.00
OncoSec Medical (ONCS) United States $0.073B 0.00
Alimera Sciences (ALIM) United States $0.073B 0.00
Oncolytics Biotech (ONCY) Canada $0.069B 0.00
Celldex Therapeutics (CLDX) United States $0.069B 0.00
Bellerophon Therapeutics (BLPH) United States $0.068B 0.00
Novelion Therapeutics (NVLN) Canada $0.067B 0.00
Oncobiologics (ONS) United States $0.066B 0.00
CorMedix Inc (CRMD) United States $0.065B 0.00
TRACON Pharmaceuticals (TCON) United States $0.062B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.060B 0.00
Entera Bio (ENTX) Israel $0.060B 0.00
Caladrius Biosciences (CLBS) United States $0.058B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.057B 0.00
VIVUS (VVUS) United States $0.055B 0.00
Curis (CRIS) United States $0.054B 0.00
Celsion (CLSN) United States $0.050B 0.00
Zosano Pharma (ZSAN) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Advaxis (ADXS) United States $0.045B 0.00
AZURRX BIOPHARM (AZRX) United States $0.045B 0.00
Eyenovia (EYEN) United States $0.044B 0.00
Moleculin Biotech (MBRX) United States $0.044B 0.00
GTx (GTXI) United States $0.043B 0.00
Aileron Therapeutics (ALRN) United States $0.042B 0.00
BioPharmX (BPMX) United States $0.039B 0.00
AquaBounty Technologies (AQB) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.037B 0.00
Proteon Therapeutics (PRTO) United States $0.036B 0.00
CytRx (CYTR) United States $0.036B 0.00
GENPREX INC (GNPX) United States $0.036B 0.00
VistaGen Therapeutics (VTGN) United States $0.035B 0.00
Gemphire Therapeutics (GEMP) United States $0.034B 0.00
Vical (VICL) United States $0.031B 0.00
VTv Therapeutics (VTVT) United States $0.029B 0.00
AEterna Zentaris (AEZS) United States $0.028B 57.67
OvaScience (OVAS) United States $0.028B 0.00
Cellect Biotechnology (APOP) Israel $0.027B 0.00
Benitec Biopharma (BNTC) Australia $0.026B 0.00
Soligenix (SNGX) United States $0.025B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.025B 0.00
Arsanis (ASNS) United States $0.024B 0.00
ATyr Pharma (LIFE) United States $0.023B 0.00
Edge Therapeutics (EDGE) United States $0.023B 0.00
Cleveland BioLabs (CBLI) United States $0.022B 0.00
RestorGenex (DFFN) United States $0.021B 0.00
Galena Biopharma (SLS) United States $0.021B 0.00
Fibrocell Science Inc (FCSC) United States $0.020B 0.00
Adial Pharmaceuticals (ADIL) United States $0.019B 0.00
Prana Biotechnology (PRAN) Australia $0.019B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
Therapix Biosciences (TRPX) Israel $0.018B 6.82
Genetic Technologies (GENE) Australia $0.018B 0.00
Histogenics (HSGX) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.016B 0.00
Neuralstem (CUR) United States $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
AmpliPhi Biosciences (APHB) United States $0.015B 0.00
TrovaGene (TROV) United States $0.014B 0.00
Vital Therapies (VTL) United States $0.013B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.011B 0.00
IBio (IBIO) United States $0.010B 0.00
Synthetic Biologics (SYN) United States $0.010B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.009B 0.00
Oragenics (OGEN) United States $0.009B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.008B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
Stellar Biotechnologies (SBOT) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Aytu Bioscience (AYTU) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00